Background: African horse sickness (AHS) is a devastating viral disease of equids that was first recorded in 1327. Currently, prevention and control of the disease are based on attenuated vaccines and midge control. It has been shown that attenuated Orbivirus vaccines are not always safe as they may reverse to virulence.
Objectives: In the Emirate of Dubai, a vaccination experiment was carried out with an inactivated AHS vaccine produced at the Central Veterinary Research Laboratory (CVRL), Dubai, UAE to investigate the humoral antibody response of AHS-naïve horses to this vaccine. Our vaccination experiment was performed to establish an AHS vaccine bank in the UAE to protect horses from the disease in case of an outbreak. Therefore, CVRL established an inactivated AHS vaccine containing all nine serotypes which induce high neutralising antibodies.
Study Design: A total of 10 horses kept in a desert isolation area were subcutaneously and intramuscularly vaccinated with an inactivated vaccine containing all nine AHS serotypes previously isolated from Kenyan horse fatalities. Primary immunisation was followed by two booster immunisations 4 weeks and 6 months apart. After 13 months, an annual booster was administered.
Methods: Blood samples were regularly withdrawn for ELISA and virus neutralisation testing. Additionally, EDTA blood was tested every second day for 14 days post each vaccination for the presence of AHS virus or its RNA.
Results: Results show that ELISA and virus neutralising antibodies appeared after the first booster, declined after 4-6 months and therefore three vaccinations and an annual vaccination are necessary to achieve high protective virus neutralising antibodies.
Main Limitations: No challenge infection was carried out due to the lack of a safe facility in the UAE.
Conclusion: Before more advanced AHS vaccines become a reality, inactivated vaccines containing all nine serotypes should be used as they produce high ELISA and neutralising antibodies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/evj.13363 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
While immune-checkpoint blockade (ICB) has revolutionized treatment of metastatic melanoma over the last decade, the identification of broadly applicable robust biomarkers has been challenging, driven in large part by the heterogeneity of ICB regimens and patient and tumor characteristics. To disentangle these features, we performed a standardized meta-analysis of eight cohorts of patients treated with anti-PD-1 (n=290), anti-CTLA-4 (n=175), and combination anti-PD-1/anti-CTLA-4 (n=51) with RNA sequencing of pre-treatment tumor and clinical annotations. Stratifying by immune-high vs -low tumors, we found that surprisingly, high immune infiltrate was a biomarker for response to combination ICB, but not anti-PD-1 alone.
View Article and Find Full Text PDFAnalysis of invasive group A streptococcal puerperal sepsis in Calgary, Alberta: clinical consequences and policy implications.
Infect Control Hosp Epidemiol
October 2024
Department of Medicine, University of Calgary and Alberta Health Services, Calgary, AB, Canada.
We analyzed invasive group A streptococcal puerperal sepsis cases in a large health zone in Alberta, Canada between 2013 and 2022. Of the 21 cases, 85.7% were adjudicated as hospital/delivery-acquired, with 2 clusters having identical isolates found through whole genome sequencing.
View Article and Find Full Text PDFIdentification of three novel linear B-cell epitopes on VP7 of African horse sickness virus using monoclonal antibodies.
Vet Microbiol
November 2024
State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China; Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou 730046, China. Electronic address:
Article Synopsis
- * The research involved creating a recombinant version of the VP7 protein in E. coli and identifying four monoclonal antibodies that recognize specific B-cell epitopes on this protein through various immunological methods.
- * Findings revealed conserved epitopes among different AHSV serotypes, which could aid in developing better diagnostic tools and potential vaccine strategies against AHS.
Determinants of Post-COVID Ill-Health in a Cohort of Canadian Healthcare Workers.
J Occup Environ Med
January 2025
From the Division of Preventive Medicine, University of Alberta, Edmonton, Alberta, Canada (T.Z., Q.D.-M., N.C.); Division of Occupational Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada (A.A.); Department of Environmental and Occupational Health, Drexel University, Philadelphia, Pennsylvania (I.B.); Research Department, Institut de recherche Robert-Sauvé en santé et en sécurité du travail, West Montreal, Quebec, Canada (F.L.); and Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada (S.R.).
Objective: We aimed to estimate prevalence of post-COVID conditions (PCCs) among healthcare workers (HCWs) and to identify predisposing factors.
Methods: A cohort of Canadian HCWs completed four questionnaires during the pandemic. At the final questionnaire, HCWs reported conditions attributed to earlier COVID-19.
Long-term Health Outcomes After Hospital Discharge Among Children Hospitalized for MIS-C or COVID-19, September 29, 2021, to June 21, 2022.
Pediatr Infect Dis J
November 2024
COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Background: The long-term effects of children hospitalized with multisystem inflammatory syndrome in children (MIS-C) or acute COVID-19 are not well known. Our objective was to determine long-term outcomes.
Methods: Children hospitalized with MIS-C or COVID-19 at 3 US hospitals from March 2020, through February 2021 were followed to assess health through 2 years post-hospitalization using medical records and patient surveys.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!